Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
49.61
-0.71 (-1.41%)
At close: Jul 20, 2026, 4:00 PM EDT
49.04
-0.57 (-1.15%)
Pre-market: Jul 21, 2026, 8:44 AM EDT

Novo Nordisk Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
221,406227,179382,071461,264304,575256,424
Market Cap Growth
-22.89%-40.54%-17.17%51.44%18.78%58.68%
Enterprise Value
240,446243,514392,741460,786304,893257,825
Last Close Price
49.6150.8886.02103.4667.6756.00
PE Ratio
11.7714.0627.2437.5338.4735.31
PS Ratio
4.384.689.4313.4111.9611.91
PB Ratio
7.077.4519.0829.2425.3523.70
P/TBV Ratio
3.023.5411.7510.089.459.35
P/FCF Ratio
23.9824.5337.1037.4931.7134.46
P/OCF Ratio
12.1212.1422.6428.6126.8230.49
EV/Sales Ratio
4.755.029.6913.4011.9711.97
EV/EBITDA Ratio
8.9610.3619.0927.7925.7826.07
EV/EBIT Ratio
9.6512.1421.9330.3428.3228.75
EV/FCF Ratio
26.0426.2938.1437.4531.7434.64
Debt / Equity Ratio
0.720.610.620.190.290.18
Debt / EBITDA Ratio
0.860.880.700.240.310.41
Debt / FCF Ratio
1.242.221.390.330.390.55
Net Debt / Equity Ratio
0.610.540.53-0.030.030.13
Net Debt / EBITDA Ratio
0.730.700.52-0.030.030.14
Net Debt / FCF Ratio
1.051.761.04-0.040.030.19
Asset Turnover
0.590.610.740.840.810.83
Inventory Turnover
1.181.301.231.271.291.24
Quick Ratio
0.490.480.460.570.620.60
Current Ratio
0.790.800.740.820.890.86
Return on Equity (ROE)
36.97%60.70%80.78%88.07%72.00%71.24%
Return on Assets (ROA)
21.11%19.86%26.12%29.51%27.60%27.93%
Return on Invested Capital (ROIC)
37.17%38.68%63.04%86.76%72.64%67.32%
Return on Capital Employed (ROCE)
44.91%44.38%65.34%77.37%69.49%69.14%
Earnings Yield
8.50%7.11%3.67%2.66%2.60%2.83%
FCF Yield
4.17%4.08%2.70%2.67%3.15%2.90%
Dividend Yield
2.59%3.60%1.61%1.01%1.19%1.28%
Payout Ratio
30.39%50.53%43.71%37.96%45.57%45.06%
Buyback Yield / Dilution
0.20%0.34%0.71%1.10%1.34%1.58%
Total Shareholder Return
2.79%3.94%2.31%2.11%2.53%2.86%
SEC Filings: 10-K · 10-Q